ROCHE DIAGNOSTICS HEMATOLOGY, INC. – Trademark Portfolio

Entity Type: 03

ROCHE DIAGNOSTICS HEMATOLOGY, INC. has 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Filings span 4 Nice Classification classes, led by Class 1 (Chemicals) and Class 10 (Medical Apparatus). This trademark owner is based in WESTBOROUGH, MA.

69 MILK STREET

SUITE 120

WESTBOROUGH, MA 01581

13 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ROCHE DIAGNOSTICS HEMATOLOGY, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (5 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

10
Medical Apparatus (5 filings)

Surgical, medical, dental and veterinary apparatus and instruments

9
Computers & Electronics (3 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does ROCHE DIAGNOSTICS HEMATOLOGY, INC. have?

ROCHE DIAGNOSTICS HEMATOLOGY, INC. has 13 U.S. trademarks filed with the USPTO.

What trademark classes does ROCHE DIAGNOSTICS HEMATOLOGY, INC. file in?

ROCHE DIAGNOSTICS HEMATOLOGY, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 3 (Cosmetics & Cleaning). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What is ROCHE DIAGNOSTICS HEMATOLOGY, INC.'s trademark registration success rate?

ROCHE DIAGNOSTICS HEMATOLOGY, INC. has a 0% trademark registration rate, with 0 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.